Loblaw Companies Limited Q3 2026 Earnings Recap
Published November 21, 2026
L.TO +1.2% after the report
Loblaw’s shares rose 1.2% after a quarter of steady growth and reaffirmed full-year outlook. Food same-store sales growth was modest at 0.6%, while drug retail and digital sales provided stronger momentum.
The numbers
Reported results against what analysts expected.
Earnings per share
$0.74
vs $0.74 expected · beat by 0.0%
Revenue
19970890000
vs 19869730000 expected · beat by 0.5%
Stock after the report
+1.25%
close to close around the results
Key takeaways
From the Q3 2026 earnings call.
- Retail sales increased 3.6% to CAD 19.9 billion; retail adjusted EBITDA rose 6.9% and margin expanded 30 basis points.
- Adjusted EPS from continuing operations grew 8.8%, including only one month of EQ Bank earnings; management said three months would have implied low-double-digit growth. Full-year adjusted EPS growth guidance remains high single digits.
- Food same-store sales rose 0.6%, while hard-discount comparable sales grew above 2%; management said food same-store sales are currently trending higher in Q4.
- Drug retail sales grew 5.7%, with same-store sales up 4.8%; pharmacy and healthcare services same-store sales increased 7.6%. Online sales rose 16.9%.
- Gross margin increased 20 basis points to 31.3% and the SG&A rate improved 20 basis points to 20%; free cash flow from continuing operations declined CAD 23 million year over year to CAD 324 million.
Your portfolio
Track earnings for the stocks you own
Add your portfolio once, by connecting your broker or importing your history. When a company you hold reports, you get a recap like this one by email, with how the stock moved.
Also published on November 21, 2026
This summary was written by AI from the official earnings call transcript. It is for information only and is not financial advice. For L.TO's price history and fundamentals, see the L.TO stock page.